The production, purification and preliminary characterization of actinocarcin have been reported in a previous paper.1) In this paper, further characterization and degradation studies as well as C-terminal structure determination of actinocarcin are described.
Amino-acid Composition and Molecular-weight Determination
The molar ratio of amino acids in actinocarcin, estimated from amino-acid analysis after acid hydrolysis and tryptophan analysis by the ultraviolet-absorption method ,2) was as follows; and DNS-valine were identified by silica gel thin-layer chromatography. To confirm this result, EDMAN degradation5) of actinocarcin was performed with the automatic sequence analyzer JEOL-JAS-47K. The PTH-amino acid obtained from the first degradation step, was subjected to gas chromatography and the result is shown in Fig. 1 . PTH-alanine and PTH-valine were detected in about equal molar concentration. Thus, actinocarcin has two N-terminal amino acids, namely, valine and alanine.
Hydrazinolysis6) of actinocarcin liberated one amino acid which was identified as tryptophan by amino-acid analysis using STEIN-MOORE'S method.7) Therefore, the C-terminal amino acid of actinocarcin is tryptophan.
Cyanogen Bromide Cleavage8)
Actinocarcin contains two moles of methionine and was selectively cleaved at the methionine sites by cyanogen bromide into three fragments. The fragments were separated by Sephadex G-25 column chromatography and were named BrCN-I, BrCN-II and BrCN-III, respectively, according to the sequence of elution from the column. Amino-acid analysis after acid hydrolysis gave the following results. Fig. 2 and Fig. 3 . The first step removed glycine, the second leucine and the third aspartic acd.
As the C-terminus of BrCN-III is tryptophan, the residual arginine is the fourth amino acid. Accordingly, the primary structure (amino acid sequence) of BrCN-III is Gly-Leu-Asp-Arg-Trp. Methionine (0.02,ftM) was added as internal standard.
Step 1
Step 2 VOL. XXIX NO. To correct the absorbancies at these wave lengths, the value was also measured at 340 and 370 nm. Contents of tryptophan and tyrosine were calculated by using the given molar extinction coefficients and these corrected absorbancies. N-Terminal Amino-Acid Analysis: Actinocarcin (0.9 mg) was dissolved in 0.2 ml of 0.1 M triethylamine-H2CO3 buffer and 0.2 ml of 0.5 % dansyl chloride4) in acetone was added to the buffer solution. The reaction was allowed to proceed for 2 hours at 37°C. The reaction mixture was then dried in vacuo and the residue was dissolved in 0.5 ml of constant boiling HCl. Hydrolysis was carried out at 110°C for 18 hours in a sealed and evacuated tube. The hydrolysate was evaporated to dryness in vacuo and the residue was applied to the silica gel thinlayer plate using the solvent system, chloroform-benzyl alcohol-acetic acid (50:5:0.1, v/v). DNSvaline and DNS-alanine were identified by tlc.
C-Terminal Amino-Acid Analysis: Actinocarcin (1.3 mg) was dissolved in 0.5 ml of anhydrous hydrazine and left at 105°C in a sealed tube for 8 hours. Excess hydrazine was removed by lyophilization. The residue was dissolved in 2 ml of water and 0.5 ml of benzaldehyde was added. The mixture was immediately shaken vigorously for 1 hour at room temperature and the resulting hydrazides were removed by centrifugation. The supernatant was washed three times with ether to remove exess benzaldehyde and then lyophilized. The residue was dissolved in 1 ml of citrate buffer, pH 2.2, and the solution was subjected to amino-acid analysis.
Molecular Weight Determination by the ARCHIBALD's Method:3) Actinocarcin (9 mg) was dissolved in 1.8 ml of 0.01 M NaCl and the solution was centrifuged at 29,400 rpm to observe the ARCHIBALD pattern. The same solution of actinocarcin was centrifuged at 21,410 rpm to observe the SCHLIEREN pattern. The molecular weight of actinocarcin was calculated by using the value obtained from the ultracentrifuge experiments described above.
Cyanogen Bromide Cleavage:8) Actinocarcin (107 mg) was dissolved in 11 ml of 70% formic acid and 70 mg of crystalline cyanogen bromide was added. The reaction was allowed to proceed for 24 hours at room temperature in a tightly stoppered flask. After cyanogen bromide cleavage, 20 ml of water was added to the reaction mixture and the solution was evaporated in vacuo to remove excess cyanogen bromide and formic acid. The residue was dissolved 3 mg) . Amino-acid analysis and N-terminal amino-acid determination of these Were carried out by the similar procedure as described for actinocarcin. EDMAN Degradation5) of BrCN-III: BrCN-III (0.5 mg) was dissolved in 0.5 ml of distilled water and the solution was transferred to the reaction cup of an automatic sequence analyzer. Then EDMAN degradation of BrCN-III was carried out and repeated automatically by the sequence analyzer. The solution of the thiazolinone derivative formed at each degradation step was sent out from the instrument into the fraction tube. The solution was transferred to a centrifuge tube and was evaporated to dryness in a stream of N.. One ml of 1 N HCl was added to the dry sample of the thiazolinone. After the tube was heated at 80°C for 10 minutes, the solution of the resulting phenylthiohydantoin (PTH) amino acid was extracted repeatedly with ethyl acetate (3 x 1 ml) and the extracts were combined. The organic phase was evaporated to dryness in a jet of N2. Then the dry samples of PTH amino acids obtained by the procedure above described, were identified by silica gel thin-layer chromatography and gas chromatography. Xylene-isopropyl alcohol (1:1, v/v) was used as developing solvent for t1c. Gas Chrom Q was used as the solid support and SE-30 was used as the silicone liquid phase for glc.
EDMAN Degradation of Actinocarcin: Actinocarcin (4.5 mg) was used and the PTH amino acid obtained from the first degradation step was identified by gas chromatography by a procedure similar to that described for BrCN-III.
